Building trust as EU member states - old and new - settle into the new regime
This article was originally published in Clinica
There is a certain amount of apprehension on both sides when it comes to free trade between the new EU accession countries and the previously existing EU 15 in medical devices and diagnostics.
You may also be interested in...
As sector awaits its aducanumab filing with bated breath, Biogen invests again in early stage neuroscience.
In case you missed it: catch up with snippets from interviews with industry leaders recently published by In Vivo.
While good clinical practice inspectors in the UK and the US collaborate on matters of common interest, they say that mutual recognition is simply not possible.